An interventional study of Whole-Body High-Intensity Interval Training (WB-HIIT) in Overweight and/or Obesity, sponsored by Université Libre de Bruxelles. Recruiting at 1 site in Belgium. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by Université Libre de Bruxelles · Not applicable, Interventional, and Basic science
This study aims to evaluate the effects of a supervised whole-body high-intensity interval training (WB-HIIT) program on physical fitness and health outcomes in adults with overweight and obesity. WB-HIIT is a practical and time-efficient training modality based on body-weight exercises performed at high intensity with short recovery intervals. It may offer an accessible approach for improving health in individuals with excess body weight.
Participants aged 18 to 55 years with a body mass index (BMI) between 25 and 35 kg/m² will take part in a supervised 10-week WB-HIIT program, performed in small groups and led by trained exercise professionals. Before and after the intervention, participants will undergo assessments including DXA-based body composition analysis, fasting blood sampling, muscular strength testing, a Chester step test, a maximal graded treadmill exercise test with gas-exchange analysis to determine VO₂peak, and functional evaluations (chair-stand, arm-curl, and 6-minute walk test). Physical activity and dietary intake will also be recorded.
The primary objective of the study is to assess whether WB-HIIT improves cardiorespiratory fitness (VO₂peak) in adults with overweight. Secondary objectives include evaluating changes in muscular strength, body composition, metabolic markers, and functional capacity.
The results may help determine whether an equipment-free WB-HIIT program can serve as an effective and accessible training approach for improving health and physical fitness in adults with overweight and obesity.
This study investigates the physiological, functional, and metabolic effects of a supervised whole-body high-intensity interval training (WB-HIIT) program conducted entirely in person in adults with overweight and obesity.
Overweight and obesity are associated with decreased cardiorespiratory fitness, metabolic impairments, and increased risk of chronic diseases. In contrast, regular physical activity is known to improve cardiorespiratory fitness, metabolic health, body composition, strength, and quality of life. WB-HIIT, which involves body-weight exercises performed at high intensity with controlled recovery intervals, provides a time-efficient, equipment-free training modality that can be adapted for individuals with excess body weight.
A total of 40 adults aged 18 to 55 years with a BMI between 25 and 35 kg/m² will be recruited and allocated to an intervention and control group. In the intervention group, participants will complete a 10-week supervised WB-HIIT program consisting of 2 to 3 sessions per week. Training sessions will include 8 to 12 whole-body exercises targeting major muscle groups, performed in intervals lasting 20 to 60 seconds with recovery periods adjusted according to participant progression. Intensity will be monitored through heart rate and perceived exertion (Borg CR-10 scale), and progression will be achieved by modifying the number of sets, exercise complexity, and work-to-rest ratio.
All participants will undergo comprehensive pre- and post-intervention evaluations. Body composition will be measured using DXA, and anthropometric measurements will include waist circumference and BMI. Cardiometabolic health will be assessed through fasting blood sampling measuring glucose, insulin, HbA1c, lipid profile, hepatic markers, and additional exploratory biomarkers. Cardiorespiratory fitness will be evaluated using a maximal graded treadmill test with gas exchange analysis to determine VO₂peak and the Chester step test. Functional performance will be assessed through the 30-second chair-stand test, arm-curl test, and 6-minute walk test. Muscular strength will be evaluated through 3-repetition maximum (3-RM) testing and fatigue protocols at 60% of 1-RM for the leg-press and bench-press exercises. Physical activity and dietary habits will also be evaluated before and after the intervention.
The primary outcomes of the study are the changes in VO₂peak and muscle strength following the intervention. Secondary outcomes include changes in body composition, metabolic parameters, and functional capacity. Statistical analyses will include repeated-measures ANOVA and between-group comparisons using parametric or non-parametric methods as appropriate.
This study aims to deepen understanding of the effects of supervised WB-HIIT in overweight adults and to identify practical, scalable training methods that can be implemented in community or clinical settings. The findings may guide the development of accessible exercise-based health strategies for improving fitness and metabolic health in this population.
3,599 studies on the registry are indexed under Overweight; 852 are open to participants now.
This study's planned enrollment of 40 is below the median of 78 across 3,120 interventional studies indexed under Overweight.
Browse Overweight studies →Université Libre de Bruxelles is the lead sponsor of 45 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A supervised whole-body high-intensity interval training (WB-HIIT) program performed in small groups. Participants complete 2 to 3 sessions per week for 10 weeks. Each session includes a warm-up followed by 8 to 12 whole-body exercises performed at high intensity for 20-60 seconds with recovery periods of 20-60 seconds. Progression is applied by adjusting exercise complexity, number of sets, and work-to-rest ratio. Heart rate and perceived exertion (Borg CR-10 scale) are monitored.
Behavioral: Whole-Body High-Intensity Interval Training (WB-HIIT)
Participants in the control group do not receive structured exercise training. They maintain their usual lifestyle and complete the same pre- and post-intervention assessments as the intervention group.
A structured WB-HIIT program using body-weight exercises such as squats, lunges, mountain climbers, and similar multi-joint movements. Sessions last 35-50 minutes and include 3 to 4 sets of interval blocks performed at high intensity. The training is supervised by qualified exercise professionals.
Peak oxygen consumption (VO₂peak)
Peak oxygen consumption (VO₂peak) will be measured during a maximal graded treadmill exercise test with gas analysis to assess changes in cardiorespiratory fitness following the 10-week WB-HIIT program. VO₂peak will be expressed in mL·kg-¹·min-¹.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Muscular strength
Maximal dynamic strength will be assessed using 3-repetition maximum (3-RM) tests on the leg press and bench press.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Estimated VO₂max from the Chester Step Test
Cardiorespiratory fitness will also be estimated using the Chester Step Test to evaluate submaximal aerobic capacity.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Body composition
Total and segmental (i.e., arms, legs and trunk) body fat mass, lean mass, and visceral fat will be assessed using dual-energy X-ray absorptiometry (DXA). They will all be expressed in kg.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Muscular endurance (fatigue tests at 60% 1-RM)
Muscular endurance will be evaluated by recording the number of repetitions performed at 60% of the estimated 1-RM for leg press and bench press.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Functional performance (chair-stand test)
Lower-body function will be assessed using the 30-second chair-stand test.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Upper-body functional performance (arm-curl test)
Upper-body functional performance will be measured using the 30-second arm-curl test with standardized weights (2 kg for women, 4 kg for men).
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Functional capacity (6-minute walk test)
Functional aerobic capacity will be assessed during a standardized 6-minute walk test, recording distance walked and recovery heart rate.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Blood biomarkers
Fasting blood markers will include glucose, insulin, HbA1c, lipid profile (total cholesterol, HDL, triglycerides), liver enzymes, and exploratory metabolic biomarkers.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Waist circumference
Waist circumference will be measured at the midpoint between the lower rib and iliac crest to assess changes in abdominal adiposity.
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Physical activity level using the International Physical Activity Questionnaire
Self-reported physical activity will be assessed using the short format of the International Physical Activity Questionnaire (IPAQ-short form). The IPAQ-short form assesses physical activity over the past seven days by recording time spent in vigorous activity, moderate activity, walking, and sitting. It converts the time spent in different physical activity intensities into total energy expenditure, expressed in MET-minutes per week. Walking, moderate activity, and vigorous activity are assigned MET values of 3.3, 4.0, and 8.0 respectively. Based on an individual's responses, the physical activity level can be expressed continuously (MET-min per week), or categorised has low, moderate and high (please refer to: https://sites.google.com/view/ipaq/score). Higher values/scores mean a higher level of physical activity.
Time frame: At Baseline
Dietary intake (3-day food record)
Dietary intake will be evaluated using a 3-day food record analyzed with standardized nutrition software.
Time frame: The outcome will be assessed once at baseline and once during the week following completion of the whole-body high-intensity interval training intervention.
Weight
Weight will be measured using a scale (in kilograms).
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Height
Height will be measured using stadiometer (in meters).
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Body mass index
Weight and height will be combined to report body mass index, expressed in kg/m²
Time frame: The outcome will be assessed once at baseline and within 72 hours after the last session of the whole-body high-intensity interval training intervention.
Plan to share: No — Individual participant data will not be shared due to confidentiality requirements and restrictions imposed by the ethics committee.
Started Nov 2022 (actual). Primary completion is estimated for Jun 2026, 43 months after the start.
Of 1,300 non-industry interventional studies with no phase under Overweight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 38. This study's planned 43 months is above that.
Counting every sponsor, half of 1,411 studies reached it within 17 months; a quarter within 8 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université Libre de Bruxelles